نتائج البحث - "Lisyanskaya, Alla"

المصدر: Khattak , H , Malhas , R , Craciunas , L , Afifi , Y , Amorim , C A , Fishel , S , Silber , S , Gook , D , Demeestere , I , Bystrova , O , Lisyanskaya , A , Manikhas , G , Lotz , L , Dittrich , R , Colmorn , L B , Macklon , K T , Hjorth , I M D , Kristensen , S G , Gallos , I & Coomarasamy , A 2022 , ' Correction to : Fresh and cryopreserved ovarian tissue transplantation for preserving ....

العلاقة: https://pure.au.dk/portal/en/publications/09e92253-059d-44c9-bb91-3a8bf1ca493cTest

الإتاحة: https://doi.org/10.1093/humupd/dmac015Test
https://pure.au.dk/portal/en/publications/09e92253-059d-44c9-bb91-3a8bf1ca493cTest
http://www.scopus.com/inward/record.url?scp=85129998282&partnerID=8YFLogxKTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989727/pdf/dmac015.pdfTest

View record in BASE

5

دورية أكاديمية

Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial

المؤلفون: Moore, Kathleen N, Oaknin Benzaquen, Ana Mazaltob, Friedlander, Michael, Lisyanskaya, Alla, Scambia, Giovanni, Colombo, Nicoletta

المساهمون: Institut Català de la Salut, Colombo N University of Milan-Bicocca and IEO European Institute of Oncology IRCCS, Milan, Italy. Moore K Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK, United States. Scambia G Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica, Rome, Italy. Oaknin A Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Friedlander M University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, Australia. Lisyanskaya A St Petersburg City Oncology Dispensary, St Petersburg, Russia, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Ovaris - Càncer - Tractament, Avaluació de resultats (Assistència sanitària), DISEASES::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

وصف الملف: application/pdf

العلاقة: Gynecologic Oncology;163(1); https://doi.org/10.1016/j.ygyno.2021.07.016Test; Colombo N, Moore K, Scambia G, Oaknin A, Friedlander M, Lisyanskaya A, et al. Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial. Gynecol Oncol. 2021 Oct;163(1):41–9.; https://hdl.handle.net/11351/7785Test; 000719043200008

الإتاحة: https://doi.org/10.1016/j.ygyno.2021.07.016Test
https://hdl.handle.net/11351/7785Test

View record in BASE

6

دورية أكاديمية

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

المؤلفون: Poveda, Andrés, Floquet, Anne, Ledermann, Jonathan A, Asher, Rebecca, Penson, Richard T, Oza, Amit M, Korach, Jacob, Huzarski, Tomasz, Pignata, Sandro, Friedlander, Michael, Baldoni, Alessandra, Park-Simon, Tjoung-Won, Tamura, Kenji, Sonke, Gabe S, Lisyanskaya, Alla, Kim, Jae-Hoon, Filho, Elias Abdo, Milenkova, Tsveta, Lowe, Elizabeth S, Rowe, Phil, Vergote, Ignace, Pujade-Lauraine, Eric, Byrski, Tomasz, Pautier, Patricia, Harter, Philipp, Colombo, Nicoletta, Scambia, Giovanni, Nicoletto, Maria, Nussey, Fiona, Clamp, Andrew, Penson, Richard, Oza, Amit, Poveda Velasco, Andrés, Rodrigues, Manuel, Lotz, Jean-Pierre, Selle, Frédéric, Ray-Coquard, Isabelle, Provencher, Diane, Prat Aparicio, Aleix, Vidal Boixader, Laura, Scott, Clare, Yunokawa, Mayu, Medioni, Jacques, Pécuchet, Nicolas

المساهمون: AstraZeneca

المصدر: The Lancet Oncology ; volume 22, issue 5, page 620-631 ; ISSN 1470-2045

مصطلحات موضوعية: Oncology

الإتاحة: https://doi.org/10.1016/s1470-2045Test(21)00073-5
https://api.elsevier.com/content/article/PII:S1470204521000735?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1470204521000735?httpAccept=text/plainTest

View record in BASE

7

دورية أكاديمية

Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial

المصدر: Gynecologic Oncology ; volume 163, issue 1, page 41-49 ; ISSN 0090-8258

مصطلحات موضوعية: Obstetrics and Gynecology, Oncology

الإتاحة: https://doi.org/10.1016/j.ygyno.2021.07.016Test
https://api.elsevier.com/content/article/PII:S0090825821005783?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0090825821005783?httpAccept=text/plainTest

View record in BASE

8

دورية أكاديمية

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

المساهمون: Disilvestro, P, Banerjee, S, Colombo, N, Scambia, G, Kim, B, Oaknin, A, Friedlander, M, Lisyanskaya, A, Floquet, A, Leary, A, Sonke, G, Gourley, C, Oza, A, González-Martín, A, Aghajanian, C, Bradley, W, Mathews, C, Liu, J, Mcnamara, J, Lowe, E, Ah-See, M, Moore, K

مصطلحات موضوعية: Olaparib

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36082969; info:eu-repo/semantics/altIdentifier/wos/WOS:000928326300022; volume:41; issue:3; firstpage:609; lastpage:617; numberofpages:9; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/10281/398287Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85146484599

الإتاحة: https://doi.org/10.1200/JCO.22.01549Test
https://hdl.handle.net/10281/398287Test

View record in BASE